Rezultati

eNauka >  Results >  Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial
Title Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial
Authors: Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Janki; Zueger, Patrick; De, Vlam K
Issue Date: 2022
Publication: ANNALS OF THE RHEUMATIC DISEASES
ISSN: 0003-4967 Annals of the Rheumatic Diseases Search Idenfier
Type: Conference Paper
Collation: vol. 81 br. Suppl 1 str. 1569-1570
DOI: 10.1136/annrheumdis-2022-eular.1371
WoS-ID: 000850279006285
URI: https://enauka.gov.rs/handle/123456789/819043
Project: AbbVie Inc.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.